Cite
Grindel B, Li Q, Arnold R, et al. Correction: Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients. Oncotarget. 2016;7(37):60775doi: 10.18632/oncotarget.11976.
Grindel, B., Li, Q., Arnold, R., Petros, J., Zayzafoon, M., Muldoon, M., Stave, J., Chung, L. W., & Farach-Carson, M. C. (2016). Correction: Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients. Oncotarget, 7(37), 60775. https://doi.org/10.18632/oncotarget.11976
Grindel, Brian, et al. "Correction: Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients." Oncotarget vol. 7,37 (2016): 60775. doi: https://doi.org/10.18632/oncotarget.11976
Grindel B, Li Q, Arnold R, Petros J, Zayzafoon M, Muldoon M, Stave J, Chung LW, Farach-Carson MC. Correction: Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients. Oncotarget. 2016 Sep 13;7(37):60775. doi: 10.18632/oncotarget.11976. PMID: 28040804; PMCID: PMC5312418.
Copy
Download .nbib